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Abstract: The present work studies the effects of topical application of nucleotides on rabbit tear 
lysozyme levels. Lysozyme values were determined by the diffusion in Agar method described 
by van Bijsterveld in 1974, and the protein amount was obtained by measuring the inhibitory 
halos around a Whatman nº1 paper disc of 5 mm in diameter. The tested nucleotides were UTP, 
Ap4A and Up4U. These compounds were topically instilled in a single-dose in one eye (with 
the contralateral eye as a control) and the lysozyme halos were measured along 5 hours. The 
obtained results showed an increase in the lysozyme concentrations of 67%, 93%, and 119% 
for UTP, Ap4A, and Up4U, respectively, over the basal levels of lysozyme. For this reason, we 
suggest these molecules as a potential treatment for the reinforcement of the tear ﬁ  lm barrier 
against ocular infection.
Keywords: lysozyme, nucleotides, tear ﬁ  lm, ocular infection, ocular protection, ocular 
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Introduction
Tear lysozyme is a high molecular weight, long chain glycolytic enzyme secreted 
by the lachrymal gland. Among the tear proteins identiﬁ  ed, lysozyme constitutes 
around 20%–40% of the total tear protein (Farris 1985) and its concentration in the 
tear ﬁ  lm is higher than in any other ﬂ  uid of the body (Fleming 1922). This protein 
has the capacity to dissolve Gram-negative bacteria walls by the enzymatic digestion 
of mucopolysaccharides (Milder 1987). Due to this bactericidal action, lysozyme has 
been considered as one of the essential elements of the protective tear ﬁ  lm barrier 
against ocular infection (Mackie and Seal 1976).
The importance of this lachrymal component has contributed to develop methods 
for its detection and measurement, as well as to correlate its concentration with ocular 
pathologies. Several studies have shown a decrease in the concentration of lysozyme in 
patients with keratoconjunctivitis sicca (van Bijsterveld 1969; Mackie 1984; Montero 
1990), suggesting that a drop off in tear lysozyme levels may constitute an important 
parameter to detect a malfunctioning lachrymal gland (Klaeger 1999).
Recently, the presence of a new family of compounds in the tear ﬁ  lm have been 
described: the diadenosine polyphosphates (Pintor, Carracedo et al 2002). These naturally 
occurring dinucleotide compounds exhibit both intracellular and extracellular physi-
ological actions, these including vasoactive properties, neuromodulatory regulation of 
neurotransmitter release or intracellular modulation of ion channels (McLennan 2000; 
Hoyle 2002). Formed by two adenosine molecules joined by a variable phosphate chain, 
they are abbreviated as ApnA (n = 2–7, where n describes the number of phosphates). 
The activity of these nucleotides on ocular tissues is being investigated, and it is known 
that they act through P2 receptors to modulate intraocular pressure in rabbits (Pintor, 
Peral, Peláez et al 2002); Ap4A and UTP improve the rate of wound healing in the cornea 
of New Zealand white rabbits (Pintor, Bautista et al 2004) and also, Ap4A, Ap5A, and Clinical Ophthalmology 2008:2(2) 262
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Ap6A, can stimulate tear secretion after single-dose topical 
application in rabbits (Pintor, Peral, Hoyle et al 2002).
In order to investigate the physiological role of nucleo-
tides onto the tear ﬁ  lm, lysozyme levels in New Zealand white 
rabbits tears have been measured after a topical application 
of the mentioned substances. The methodological approach 
used to get the lysozyme levels has been the agar diffusion 
method described by van Bijsterveld (1974). The analysis 
of the data suggests an increase in tear lysozyme levels with 
the application of the tested nucleotides.
Experimental procedures
Animals
Twelve male New Zealand white rabbits from Granja Cunicula 
San Bernardo (Navarra, Spain) weighing 2.0–2.5 kg were kept 
in individual cages with free access to food and water and 
subjected to regular cycles of light and dark (12 hours each). 
The New Zealand white rabbits were 6 months old and the 
slit lamp exam evidenced no ocular pathology or alteration 
that could affect the tear secretion. All the experiments were 
performed according to Association for Research in Vision and 
Ophthalmology (ARVO) Statement for the Use of Animals in 
Ophthalmic and Vision Research and in accordance with the 
European Communities Council Directive (86/609/EEC).
Compounds
Three nucleotides were tested along this work: UTP from 
Amersham Biosciences, Inc., (Piscataway, NJ); Ap4A from 
Sigma Chemical (St Louis, MO); Up4U (diquafosol or for-
merly INS365) kindly provided by Inspire Pharmaceuticals 
(Durham, NC, USA). The P2 antagonists employed were 
pyridoxalphosphate-6-azophenyl-2', 4'-disulfonic acid 
(PPADS), suramin and reactive blue-2 (RB-2) were pur-
chased from Sigma/RBI (Natick MA).
For single dose experiments, all the nucleotides were 
applied in a concentration of 100 μM in a volume of 10 μL 
in the tested eye. The contralateral eye was instilled with 
10 μL saline 0.9%. The P2 receptor antagonists PPADS, suramin
and RB-2 were instilled in concentrations of 100 μM (10 μL), 
30 min before the application of any of the nucleotides.
The UTP, Ap4A and Up4U nucleotides were tested twice 
in the whole sample (n = 24 each agonist). The P2 receptor 
antagonists were experienced once for each agonist in the 
whole sample (n = 12 for each agonist).
Diffusion in agar
The Diffusion in agar method was employed to measure the 
lysozyme levels in rabbit tears. Callibration curves as well as 
all the lysozyme measurements were performed as indicated 
by van Bijsterveld (1974) and Mackie and Seal (1976). 
Brieﬂ  y, the protein amount was obtained by measuring the 
inhibitory halos around a Whatman nº1 paper disc of 5 mm 
in diameter. The paper discs were placed with clamps in the 
upper bulbar conjunctiva to avoid mucus strands. When the 
tears soaked the discs; they were removed and put on Petri 
dishes with Agar medium where Micrococus lisodeikticus 
was grown. The petri dishes were then incubated at 37 ºC 
for 24 hours and ﬁ  nally the zones of lysis of Micrococus 
lisodeikticus were measured. Lysozyme standard curves for 
its quantiﬁ  cation was performed with known concentrations 
of HEL (Hen Egg Lysozyme). For the mentioned curve, the 
5 mm paper discs were weighed before and after being soaked 
by rabbit tears in order to estimate the equivalent volume of 
lysozyme solution to apply on the calibration paper discs. The 
difference in weight was the equivalent to 5 μL of lysozyme 
solution, so that volume was applied to estimate the standard 
curve. Concentrations between 0.1 mg/ml and 1.0 mg/ml of 
standard hen lysozyme were applied on the discs in a ﬁ  nal 
volume of 5 μl.
After two control measurements, 10 μL of the studied 
compound was topically instilled in one eye (taking the 
contralateral eye as a control), and the tear samples were 
collected every hour for ﬁ  ve hours. For measuring the diam-
eter of the halos, petri dishes were scanned and analyzed by 
the computer program Imagej (v.1.37, NIH, USA). Brieﬂ  y, 
scanned images of the inhibition halos were transformed into 
8-bit black and white images and further transformed into a 
binary image prior to the corresponding calculation. With this 
standardized method, errors regarding borderlines, penumbra 
and other possible problems were minimized.
Statistical analysis
The lysozyme values presented are the means ± S.D. of the 
experiments performed. Data were analyzed using the paired 
t-test and signiﬁ  cance was set at p  0.05.
Results
To determine whether these nucleotides were able to modify 
rabbit tear lysozyme levels at intervals after the nucleotide 
topical application, single doses of UTP, Ap4A, Up4U were 
applied at 100 μM (at a ﬁ  nal volume of 10 μl) (Figure 1). The 
results for the time-course of the single-dose application 
compared with the basal curve for lysozyme is represented 
in Figure 2. This Figure illustrates the behavior of the men-
tioned substances over the tear protein levels. It is possible 
to see that all the three substances increase the concentration Clinical Ophthalmology 2008:2(2) 263
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of lysozyme in the rabbit tears, and that the maximal effect is 
obtained two hours after the instillation of the corresponding 
nucleotide. This effect remained for at least 3 more hours, 
then returned to basal levels (Figure 2).
A representative experiment showing the inhibitory halos 
around Whatman n°1 paper discs in the moment of maxi-
mal effect is presented in Figure 3. These halos represent 
the zones of lysis of Micrococcus lysodeikticus due to the 
action of lysozyme. The ﬁ  rst disc shows the basal diameter 
of lysis for a control rabbit (basal lysozyme concentration 
present in tears, Figure 3a). The others showed a maximal 
increased diameter of lysis due to the action of the different 
nucleotides on the tear lysozyme levels after their topical 
application (Figure 3a).
A representative value to compare effects among nucleo-
tides can be obtained if we represent the mean of lysozyme 
concentration obtained for the period between 2 and 5 
hours – plateau – for any of the substances versus basal 
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Figure 1 Structure of uridin triphoshate, UTP,  diguanosine tetraphosphate Up4U, and diadenosine tetraphosphate, Ap4A. Clinical Ophthalmology 2008:2(2) 264
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concentration. As it is shown in Figure 3b, it is possible 
to see that the mean values for all the nucleotides showed 
a signiﬁ  cant increase in lysozyme concentrations over the 
basal level. The increase in lysozyme concentration after the 
nucleotides application was 93 % for Ap4A, 119% for Up4U 
and 67% for UTP (Figure 3b).
The activity of the substances on tear lysozyme levels 
suggests the activation of P2 nucleotide receptors. To conﬁ  rm 
this, the effects of three non-selective nucleotide receptor 
antagonists on lysozyme levels were studied: PPADS, 
suramin and RB-2. The antagonists were applied 30 minutes 
before the administration of nucleotides. The results shown in 
Figure 4 illustrate different behaviors on each compound.
Diadenosine tetraphosphate effect on lysozyme produc-
tion was signiﬁ  cantly reversed by the antagonist PPADS, 
returning the lysozyme concentration to control values. 
Neither of the other two, RB-2 or suramin was able to modify 
the effect triggered by Ap4A.
Up4U was antagonized by PPADS and suramin, the 
reduction being 42% and 52% for PPADS and suramin 
respectively. Concerning UTP, the P2 receptors antagonists 
did not antagonize this mononucleotide. Moreover, in the 
case of RB-2, there was a potentiation of UTP effect when 
compared with the effect of this nucleotide alone, showing 
an increase of almost 25% above the lysozyme concentration 
obtained when UTP is applied alone.
Discussion
This study shows for the ﬁ  rst time the physiological effect 
of Ap4A, Up4U and UTP on the tear lysozyme levels in New 
Zealand white rabbits. All the tested nucleotides showed an 
increase in the lysozyme concentrations for a single-dose 
application, which was measurable for several hours after 
the topical application of the compounds.
Since lysozyme is one of the main proteins involved 
in the protective tear ﬁ  lm barrier against ocular infection, 
together with lactoferrin, an increase in their levels may, in 
general, enhance the bactericidal action of tears, preserving 
the health of the ocular surface.
The presence of nucleotides and dinucleotides in the 
tear is suggesting their involvement in several relevant 
physiological processes of the ocular surface. We have 
added to the list of biological actions of nucleotides and 
dinucleotides the ability of these compounds to increase the 
tear concentrations of lysozyme. It is moreover relevant the 
fact of having important changes in the concentrations of 
this enzyme when Up4U or UTP are topically applied. These 
two nucleotides have not been described in tears but they 
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Figure 2 Time course of the increase of lysozyme concentrations after nucleotide instillation. The application of single doses of UTP, Up4U and Ap4A produced a gradual 
increase in lysozyme levels reaching a maximal in two hours after the application of the corresponding nucleotide and remaining above the basal levels for at least three 
more hours. Values are the mean ± SD of 4 independent experiments in triplicate.Clinical Ophthalmology 2008:2(2) 265
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behave similarly to Ap4A, suggesting that all may activate 
the same P2Y purinoceptor subtype. In this sense, the three 
tested nucleotides have been claimed to be quite selective 
for the P2Y2 purinergic receptors (Lazarowski et al 1995; 
Mundasad et al 2001). Nonetheless, the results obtained by 
means of the non-selective P2 receptor antagonists depict 
a different pattern depending on the tested nucleotide. In 
the case of Ap4A the only effective antagonist was PPADS 
while in the case of Up4U apart from PPADS, suramin was 
also able to partially reverse the dinucleotide action. One 
may expect both nucleotides to stimulate the same receptor 
or group of receptors (see the similarities in the structure 
showed in Figure 1). Taking into account our results, it seems 
that Ap4A and Up4U share some P2Y receptor activation but 
in the case of Up4U it may activate more than one, since its 
increase in lysozyme is partially blocked by suramin while 
Ap4A effect is not. This may be at least in part justiﬁ  ed by the 
fact of the presence of several P2Y receptor in the lachrymal 
Figure 3 Visualization and mean effect of nucleotides induced lysozyme concentration. (a) Agar diffusion experiments presenting the inhibitory halos obtained at the maxi-
mal effect of the nucleotides (all at 100 mM) which can be compared to basal lysozyme concentration (saline). (b) Comparative study of the mean effect of all the tested 
nucleotides (plateau) and the corresponding basal lysozyme concentration. The values represent mean ± SD of 4 independent experiments in triplicate.
*p  0.001.
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Figure 4 Effect of P2 receptor antagonists on the nucleotide-induced lysozyme concentration increase in tear. P2 receptor antagonists, assayed as described in methods, 
were tested in their ability to reverse the effects produced by the nucleotides. The values represent mean ± SD of 3 independent experiments in triplicate.
*p  0.001 and **p  0.0001.
gland and cornea (Cowlen et al 2003; Pintor, Bautista et al 
2004; Pintor, Sanchez-Nogueiro et al 2004), and also by the 
fact that Up4U is known to activate at least P2Y2 and P2Y4 
receptors (Brunschweiger and Muller 2006).
It is noteworthy the effect the antagonists of P2 receptors 
display on the UTP effect. Although one should expect that 
RB-2 might block the effect of UTP, the observed behavior 
of this antagonist shows the opposite effect. Reactive blue 
2 has been described as a very potent inhibitor of all plasma 
membrane-bound NTPDases as reported by many authors 
(Mateo et al 1996, 1997). Since RB-2 inhibits ecto-enzymes 
and does not antagonize P2Y receptors it is reasonable to see 
a potentiation of the UTP effect since it will not be degraded 
as fast as when it is applied alone.
Lysozyme levels are susceptible to present changes 
depending on various causes. For example, it has been 
described a decrease in lysozyme levels with age (Mackie 
and Seal 1976) as well as in other pathological states running 
with a drop off in tear secretion like keratoconjunctivitis 
sicca or sicca syndrome (Mackie and Seal 1984). Therefore, 
in these cases, it may be good to incorporate any of the 
indicated nucleotides as a new compound as a pharmacologi-
cal treatment to reinforce the barrier against opportunistic 
infections.
Recently, apart from the bactericidal role, Tragoulias et al 
(2005) and Millar et al (2006) have suggested that lysozyme 
contributes to lower the surface tension of the tear ﬁ  lm. In 
this case, an increase in lysozyme levels could contribute to 
stablizing the tear ﬁ  lm, thus avoiding an excessive evapora-
tion and the resulting problems on the ocular surface.
In summary, we have shown that the P2Y receptor ago-
nists, Ap4A, Up4U and UTP, are able to increase the tear 
concentrations of lysozyme. Due to the importance of this 
protein, these nucleotides may be used to fortify the tear ﬁ  lm 
barrier by increasing a naturally occurring defender against 
some ocular surface infections.Clinical Ophthalmology 2008:2(2) 267
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